Blockchain Registration Transaction Record
Silo Pharma Closes $2M Public Offering to Advance Novel Therapeutics
Silo Pharma closes $2M public offering to advance novel therapeutics. The offering includes common stock, warrants, and Series A-1 and A-2 warrants. Funds will support R&D for innovative treatments addressing stress-induced psychiatric disorders and chronic pain.

This news matters as it highlights Silo Pharma's efforts to develop innovative treatments for underserved conditions. The successful public offering will provide the company with the necessary funds to further their research and development, potentially leading to groundbreaking therapies for psychiatric disorders, chronic pain, and CNS diseases.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0x47d3fdd2d76293a9c587b85b7ee8c7183f47050e78ba909f300754e13499d719 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | urgeaxWE-83d7457e3059ffb3951ec38f8dc7299a |